1150644-76-0

Upstream product

• 1011476-56-4 3-(4-cyano-2-ethyl-6-methyl-phenyl)-propionic acid ethyl ester 
• 1350824-98-4 ethyl 3-(2-ethyl-4-(N'-hydroxycarbamimidoyl)-6-methylphenyl)acrylate 

Downstream Products

• 1150645-11-6 3-{2-ethyl-4-[5-(2-isopropylamino-6-methyl-pyrimidin-4-yl)[1,2,4]oxadiazol-3-yl]-6-methyl-phenyl}-propionic acid ethyl ester 

Relevant academic research and scientific papers

PYRAZOLE DERIVATIVES AS S1P1 AGONISTS

The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.

New pyrazole derivatives

The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.

THIOPHENE DERIVATIVES AS AGONISTS OF S1P1/EDG1

The invention relates to novel thiophene derivatives (1), their preparation and their use as pharmaceutically active compounds.Said compounds particularly act as immunomodulating agents. Formula (I).

NOVEL PYRIMIDINE DERIVATIVES

The invention relates to novel pyrimidine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents Formula (II), Formula (III), Formula (IV), Formula (V), Formula (VI), Formula (VII), Formula (VIII) or Formula (IX)

NOVEL AMINOMETHYL BENZENE DERIVATIVES

The invention relates to novel aminomethyl benzene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. (I) wherein A represents one of the groups (I), (I), (I) and